BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,287,000 | -0.0% | 27,063 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $2,288,000 | -37.1% | 27,063 | -49.9% | 0.00% | -42.9% |
| Q3 2019 | $3,637,000 | -36.2% | 53,966 | -0.1% | 0.01% | -36.4% |
| Q2 2019 | $5,703,000 | -2.3% | 54,030 | -1.0% | 0.01% | 0.0% |
| Q1 2019 | $5,838,000 | +24.0% | 54,561 | -1.3% | 0.01% | 0.0% |
| Q4 2018 | $4,709,000 | -85.0% | 55,305 | -80.1% | 0.01% | -82.3% |
| Q3 2018 | $31,435,000 | -13.2% | 278,331 | -14.3% | 0.06% | -15.1% |
| Q2 2018 | $36,216,000 | +3.9% | 324,714 | -3.4% | 0.07% | -1.4% |
| Q1 2018 | $34,843,000 | -26.5% | 336,057 | -20.9% | 0.07% | -25.3% |
| Q4 2017 | $47,396,000 | -34.5% | 425,033 | -33.8% | 0.10% | -37.3% |
| Q3 2017 | $72,341,000 | +117.1% | 641,972 | +75.0% | 0.16% | +102.6% |
| Q2 2017 | $33,315,000 | +1.3% | 366,828 | -2.1% | 0.08% | -4.9% |
| Q1 2017 | $32,900,000 | -36.3% | 374,805 | -20.0% | 0.08% | -35.4% |
| Q4 2016 | $51,661,000 | +9.4% | 468,229 | -8.2% | 0.13% | +5.8% |
| Q3 2016 | $47,201,000 | +2.6% | 510,162 | -13.8% | 0.12% | -4.0% |
| Q2 2016 | $46,025,000 | -7.0% | 591,575 | -1.4% | 0.12% | -10.7% |
| Q1 2016 | $49,467,000 | -22.8% | 599,742 | -1.9% | 0.14% | -22.7% |
| Q4 2015 | $64,059,000 | +27.3% | 611,479 | +28.0% | 0.18% | +21.5% |
| Q3 2015 | $50,323,000 | +1.1% | 477,810 | +31.2% | 0.15% | +9.6% |
| Q2 2015 | $49,800,000 | +37.8% | 364,087 | +25.6% | 0.14% | +36.0% |
| Q1 2015 | $36,128,000 | +37.8% | 289,909 | -0.0% | 0.10% | +37.0% |
| Q4 2014 | $26,215,000 | +23.7% | 289,994 | -1.2% | 0.07% | +17.7% |
| Q3 2014 | $21,186,000 | +33.0% | 293,605 | +14.7% | 0.06% | +37.8% |
| Q2 2014 | $15,930,000 | +74.4% | 256,069 | +91.2% | 0.04% | +73.1% |
| Q1 2014 | $9,135,000 | -3.0% | 133,924 | +0.0% | 0.03% | -7.1% |
| Q4 2013 | $9,417,000 | – | 133,860 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
| RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
| IRON Financial LLC | 460,000 | $513,000 | 0.40% |
| Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
| Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
| SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |